Virbac SA (France) Performance
| VIRP Stock | EUR 324.50 4.00 1.22% |
The entity has a beta of 0.31, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, Virbac SA's returns are expected to increase less than the market. However, during the bear market, the loss of holding Virbac SA is expected to be smaller as well. At this point, Virbac SA has a negative expected return of -0.0786%. Please make sure to validate Virbac SA's kurtosis, daily balance of power, and the relationship between the skewness and accumulation distribution , to decide if Virbac SA performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Virbac SA has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Virbac SA is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors. ...more
| Begin Period Cash Flow | 179.6 M | |
| Total Cashflows From Investing Activities | -51.2 M |
Virbac |
Virbac SA Relative Risk vs. Return Landscape
If you would invest 34,750 in Virbac SA on August 30, 2024 and sell it today you would lose (2,300) from holding Virbac SA or give up 6.62% of portfolio value over 90 days. Virbac SA is generating negative expected returns and assumes 2.3611% volatility on return distribution over the 90 days horizon. Simply put, 21% of stocks are less volatile than Virbac, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Virbac SA Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Virbac SA's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Virbac SA, and traders can use it to determine the average amount a Virbac SA's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0333
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | VIRP |
Estimated Market Risk
| 2.36 actual daily | 21 79% of assets are more volatile |
Expected Return
| -0.08 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.03 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Virbac SA is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Virbac SA by adding Virbac SA to a well-diversified portfolio.
Virbac SA Fundamentals Growth
Virbac Stock prices reflect investors' perceptions of the future prospects and financial health of Virbac SA, and Virbac SA fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Virbac Stock performance.
| Return On Equity | 0.15 | |||
| Return On Asset | 0.091 | |||
| Profit Margin | 0.10 % | |||
| Operating Margin | 0.16 % | |||
| Current Valuation | 2 B | |||
| Shares Outstanding | 8.44 M | |||
| Price To Earning | 70.83 X | |||
| Price To Book | 2.47 X | |||
| Price To Sales | 1.76 X | |||
| Revenue | 1.06 B | |||
| EBITDA | 201.66 M | |||
| Cash And Equivalents | 63.55 M | |||
| Cash Per Share | 7.55 X | |||
| Total Debt | 13.15 M | |||
| Debt To Equity | 98.40 % | |||
| Book Value Per Share | 96.99 X | |||
| Cash Flow From Operations | 129.9 M | |||
| Earnings Per Share | 14.05 X | |||
| Total Asset | 1.2 B | |||
| Retained Earnings | 163 M | |||
| Current Asset | 486 M | |||
| Current Liabilities | 364 M | |||
About Virbac SA Performance
By analyzing Virbac SA's fundamental ratios, stakeholders can gain valuable insights into Virbac SA's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Virbac SA has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Virbac SA has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Virbac SA produces and sells medicines and vaccines for companion and food-producing animals. Virbac SA was founded in 1968 and is headquartered in Carros, France. VIRBAC operates under Drug Manufacturers - Major classification in France and is traded on Paris Stock Exchange. It employs 4893 people.Things to note about Virbac SA performance evaluation
Checking the ongoing alerts about Virbac SA for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Virbac SA help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Virbac SA generated a negative expected return over the last 90 days | |
| Virbac SA has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations | |
| About 50.0% of the company outstanding shares are owned by insiders |
- Analyzing Virbac SA's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Virbac SA's stock is overvalued or undervalued compared to its peers.
- Examining Virbac SA's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Virbac SA's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Virbac SA's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Virbac SA's stock. These opinions can provide insight into Virbac SA's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Virbac Stock analysis
When running Virbac SA's price analysis, check to measure Virbac SA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Virbac SA is operating at the current time. Most of Virbac SA's value examination focuses on studying past and present price action to predict the probability of Virbac SA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Virbac SA's price. Additionally, you may evaluate how the addition of Virbac SA to your portfolios can decrease your overall portfolio volatility.
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |